Searched for
PRETOMANID
CPI demands action against 'medical mafia'; calls for ethical healthcare reformsThe Communist Party of India demands action against unethical healthcare practices. They state healthcare is a social obligation, not a pro...- Plans to restrict open market access to tuberculosis medicinesIndia is tightening access to anti-TB drugs Bedaquiline and Delamanid due to rising drug-resistant tuberculosis cases and potential misuse ...
- One cough too many: India's TB fight isn't quite there yetDespite India's commitment to eliminate TB by 2025, the nation grapples with a significant burden of drug-resistant cases and underreportin...
- Viatris cuts price of TB drug by 34%The decision to cut the price will help to expand access to a critical new treatment in more than 140 countries, including India, which has...
- TB Alliance in talks with government over use of new shorter BPaL RegimenIndia has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...
- Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
- BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...
- Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional accessThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...
- Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
- Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
- Mylan working with DCGI to launch new TB drug in IndiaMylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylans global president and executive...
- New treatment to be made affordable for patients: TB AlliancePretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
- USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
- States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.
Load More
